Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors
Mary Johansen, Thomas Zukowski, Paulo M. Hoff, Robert A. Newman, Dan Ni, Toni Hutto, James Abbruzzeese, Elmer Berghorn, Frederick Hausheer, Timothy Madden
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors'. Together they form a unique fingerprint.